Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116)

Ask supplier a question | View on supplier's website

Mavrilimumab (Anti-CSF2Ra/GM-CSFRa/CD116) is a monoclonal antibody that binds to the α subunit of the granulocyte-macrophage colony stimulating factor (GM-CSF) receptor and blocks intracellular signalling downstream of GM-CSF. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2532
Sku #	A2532-1mg*5
Pricing	1mg*5, $970.00

Feedback